169 related articles for article (PubMed ID: 31951790)
1. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance.
Al-Obaidy KI; Chovanec M; Cheng L
Expert Rev Anticancer Ther; 2020 Feb; 20(2):75-79. PubMed ID: 31951790
[No Abstract] [Full Text] [Related]
2. Will Testicular Germ Cell Tumors Remain Untargetable?
Aoun F; Kourie HR; Albisinni S; Roumeguère T
Target Oncol; 2016 Dec; 11(6):711-721. PubMed ID: 27184492
[TBL] [Abstract][Full Text] [Related]
3. Testis cancer: some problems still remain unsolved.
Albers P; Bokemeyer C
World J Urol; 2017 Aug; 35(8):1159-1160. PubMed ID: 28509970
[No Abstract] [Full Text] [Related]
4. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
Scardino PT; Skinner DG
Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
[No Abstract] [Full Text] [Related]
5. [Chemotherapeutic treatment regimens for germinal testicular tumors].
Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
[No Abstract] [Full Text] [Related]
6. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas].
Kenis Y; Piccart M; Beer M
Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477
[No Abstract] [Full Text] [Related]
7. Molecular targets for the treatment of testicular germ cell tumors.
Chieffi P
Mini Rev Med Chem; 2007 Jul; 7(7):755-9. PubMed ID: 17627586
[TBL] [Abstract][Full Text] [Related]
8. Current knowledge of risk factors for testicular germ cell tumors.
Fukawa T; Kanayama HO
Int J Urol; 2018 Apr; 25(4):337-344. PubMed ID: 29345008
[TBL] [Abstract][Full Text] [Related]
9. Understanding the somatic-type malignant differentiation in male germ-cell cancer: a work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol 2008;26:595-9.
Necchi A; Nicolai N; Colecchia M; Salvioni R
Urol Oncol; 2009; 27(2):218; author reply 218-9. PubMed ID: 19285238
[No Abstract] [Full Text] [Related]
10. Molecular characterization of testicular germ cell tumors: chasing the underlying pathways.
Chovanec M; Cheng L
Future Oncol; 2019 Jan; 15(3):227-229. PubMed ID: 30523697
[No Abstract] [Full Text] [Related]
11. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
[No Abstract] [Full Text] [Related]
12. Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Powles T; Shamash J; Berney D; Oliver RT
Br J Cancer; 2003 Sep; 89(6):1140-1; author reply 1141-2. PubMed ID: 12966438
[No Abstract] [Full Text] [Related]
13. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
Veenstra CM; Vaughn DJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
[TBL] [Abstract][Full Text] [Related]
14. [Prolonged regression of metastatic tumors of the testis: rejections on prognosis].
Gayet R; Cabanne F; Guerrin J
J Urol Nephrol (Paris); 1976; 82(10-11):913-6. PubMed ID: 187807
[No Abstract] [Full Text] [Related]
15. Germ cell tumors.
Bajorin DF; Motzer RJ; Bosl GJ
Curr Ther Endocrinol Metab; 1997; 6():387-92. PubMed ID: 9174777
[No Abstract] [Full Text] [Related]
16. High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor.
Connell BJ; Patel MJ; Tretter CG
Clin Genitourin Cancer; 2016 Aug; 14(4):e441-3. PubMed ID: 27055370
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of disseminated germ cell tumors of the testis].
Tiuliandin SA
Sov Med; 1987; (11):78-81. PubMed ID: 2451298
[No Abstract] [Full Text] [Related]
18. [Treatment of patients with disseminated testicular germ cell tumors].
Protsenko SA; Semenova AI; Novik AV; Teletaeva GM; Latipova DKh; Komarov YI; Nosov AK; Levchenko EV; Gafton GI; Semenov II; Klimashevsky VF
Vopr Onkol; 2015; 61(2):289-96. PubMed ID: 26087613
[TBL] [Abstract][Full Text] [Related]
19. Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors.
Cavallo F; Feldman DR; Barchi M
Int J Dev Biol; 2013; 57(2-4):273-80. PubMed ID: 23784838
[TBL] [Abstract][Full Text] [Related]
20. Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors.
Zschäbitz S; Lasitschka F; Jäger D; Grüllich C
Ann Oncol; 2016 Jul; 27(7):1356-60. PubMed ID: 27029705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
